Trading a RGC straddle lets you take a pure volatility position on Regencell Bioscience Holdings Ltd without committing to a direction. Regencell Bioscience Holdings Ltd's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate RGC straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on RGC profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Regencell Bioscience Holdings Ltd stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the RGC straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the RGC straddle is the cleanest expression of that view. Our scanner prices every RGC straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a RGC straddle into a catalyst or short a RGC straddle to harvest decay, the options straddle setups that matter are all in one place.
